About
Peloton Therapeutics, Inc. is a clinical-stage pharmaceutical company developing first-in-class medicines targeting HIF-2α for cancer and other serious diseases.
Explore Peloton Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.